Tag: Pfizer
Pfizer is doing well despite the corona losses – Uber is increasing its revenues sharply
Lufthansa continues to recover after the Corona crisis – travel boom in summer Thanks to strong demand from private travelers and high ticket prices, Lufthansa continued to put the losses…
Pfizer is doing well despite the corona losses – Uber is increasing its revenues sharply
Lufthansa continues to recover after the Corona crisis – travel boom in summer Thanks to strong demand from private travelers and high ticket prices, Lufthansa continued to put the losses…
Pfizer is doing well despite the corona losses – Uber is increasing its revenues sharply
Deutsche Post starts the year with declines The years of records are over for Deutsche Post. Because of the economic consequences of the Ukraine war and the sluggish world economy,…
Pfizer is doing well despite the corona losses – Uber is increasing its revenues sharply
Erste Group grows significantly at the start of the year At the beginning of the year, Austria’s largest financial institution, Erste Group, made strong operational gains while risk costs remained…
Pfizer is doing well despite corona losses – BP earns more than expected
Wacker Chemie with a slump in profits – bottom out? At the Munich-based specialty chemicals group Wacker, the boom has ended for the time being. Sales fell in the first…
The good years are over for Merck
Merck in the balance sheet check In 2022, Merck generated sales of more than 20 billion euros for the first time. (Photo: dpa [M]) Frankfurt The Darmstadt-based Merck Group is…
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
mRNA vaccine significantly reduces risk of skin cancer recurrence
Frankfurt Vaccines based on mRNA brought the breakthrough in the fight against the corona pandemic. Now the technology is also intended to decisively advance cancer therapy. Promising data are now…
Medicine against advanced civilization disorders
Lent is finally over. Someone in the family or circle of friends is always not eating chocolate, meat (anymore) or drinking alcohol. And then the social pressure that comes with…
Inflarx’s Covid drug approved in the US – stock rises sharply
Niels Riedemann The founder and CEO of Inflarx sees hope in the drug for seriously ill Covid patients. (Photo: InflaRx) Frankfurt An approval success that many investors no longer expected…
Biontech decides billion dollar deal for new cancer drugs
Biontech Just two weeks after the multi-million dollar deal with the US cancer specialist OncoC4, the Mainz-based company agreed on another partnership. (Photo: dpa) Frankfurt Biontech is stepping on the…
Biontech is setting itself apart from the rest of the industry more and more
Frankfurt The success of Mainz-based Biontech SE in Covid vaccine development has put the German biotech industry in the spotlight. However, hopes that the rise of the mRNA and oncology…
Diabetes drug ensures Boehringer’s growth leap
Frankfurt Strong growth in the diabetes drug Jardiance and positive currency effects brought the pharmaceutical company Boehringer Ingelheim 2022 the largest increase in sales in a good two decades. For…
Bank stocks help Wall Street recover – SVB buyers First Citizens gain 54 percent
new York US bank First Citizens BancShares’ takeover of deposits and loans from the ailing Silicon Valley Bank (SVB) has eased fears of more bank failures on Wall Street. The…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Biontech secures new cancer drug with deal worth millions
Biontech founder Ugur Sahin The company is currently also growing through acquisitions. (Photo: imago images/photothek) Frankfurt With one of its largest deals to date, Biontech is expanding its product development…
Biotech has to adjust to a dry spell in terms of financing
DNA experiment In view of the declining inflow of capital, rapid successes are required in research. (Photo: imago images/Westend61) Frankfurt The collapse of the Silicon Valley Bank (SVB) and the…
US stock exchanges close stably despite the crisis – bank shares lose significantly in value
Traders on the New York Stock Exchange US bank stocks plummet. (Photo: IMAGO/Xinhua) Frankfort, New York The fear of a banking crisis continues to keep the global capital markets in…
US stock exchanges start stable – bank shares lose significantly in value
Traders on the New York Stock Exchange US bank stocks plummet. (Photo: IMAGO/Xinhua) Frankfurt The fear of a banking crisis continues to keep the global capital markets in its grip.…